increasingli bullish driven optum recent rais pt
get bullish estim still see conserv
potenti upsid estim compani continu see similar
growth rate optum close banmedica acquisit continu deploy
capit like optumcar side believ insur outperform
though often get pushback trade histor multipl
 average would argu sustain competit advantag
tech vertic integr believ advantag earli improv
cost control growth revenu expos faster grow govern
sector medicare/medicaid drive higher valuat increas pt
upsid view potenti conserv could end
expand point care footprint unh jv walgreen medexpress
make us rethink neg stanc aet/cv deal along mani
industri exec believ strategi bring health insur retail difficult
achiev unh take bit differ better local share name
brand recruit medic staff medexpress name brand consum trust
urgent care ventur put medexpress urgent care insid exist walgreen
locat full spectrum typic capabl believ unit could seek
 urgent care asc view acquir choic given
recent dmg acquisit believ garner multipl interest parti
speed strategi ai arm race aggress
recruit ai/mlp field insur build brand name key univers
robust intern program steal brightest mind away silicon valley see
posit get increment stronger given move forward
ai spend aet second aggress ai recruit dealt blow last
week plan ny base hq data scientist locat capit
better talent pool call question cvs/remov tax incent
break tax reform impact medicaid commerci tax rate
drop tax reform lower revenu guidanc
half driven lower medicaid reimburs requir cover
hif gross see neutral medicaid name remaind
minimum rebat mainli commerci comment much
reform kept profit beyond aet believ immedi
compet away number year believ medicaid benefit
stay consid reform discuss insur around annual
benefit believ possibl could eat reform benefit time
data protect increas medic cost trend premium price competit
market-lead diversifi health care benefit inform servic compani
price close januari
ep
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
continu pursu expand optum specif optumcar
total revenu
certain popul integr care
compani data factset pjc estim
view unh recent appear consum electron show ce la vega indic
compani increas focu invest technolog consum engag link
larg show ce last week emphas compani grow focu invest ai mobil payment
blockchain believ drive consum engag higher qualiti care ultim lower cost trend
new pilot program partnership deliv continu glucos monitor enabl
optumbank member util applepay pay medic expens believ unh keen focu invest
latest technolog unmatch peer see capabl driver higher net promotor score
lower cost trend time
optuminsight continu prove valu opinion new integr elig platform help state
medicaid member access medicaid human servic benefit west virginia becam first state
incorpor new platform almost half state medicaid member access view
great exampl unit valu proposit state drive continu strong medicaid contract win rate
believ put emphasi optumhealth specif optumcar given recent acquisit
better peer ss patient revenu growth sca believ right side consumer
trend patient look lower cost set focus recent urgent care asc
see continu build system time goal market target develop
see larg growth opportun optum ralli precheck myscript function grow
signific clip also encourag unh precheck myscript function alreadi help ten thousand
consum discuss doctor prescript drug offer far almost
transact date see larg growth opportun ralli doubl membership base
view ralli valuabl tool consum technolog platform administ consum
incent also believ ralli proven use platform sever larg hospit varieti
usag search physician price appoint appoint schedul
page
believ concern pharmaceut cost overblown
believ concern pharmaceut cost cost trend light year overblown
estim new breakthrough drug come market expens recent approv harvoni fda
approv record number drug trend believ continu believ led increas competit
among drug maker caus lower price believ influx new drug includ gener compet brand drug
least off-set cost new wave cell gene therapi drug come market
view current cost trend guidanc conserv estim unh cost trend come initi
guidanc last quarter found case actual cost trend come lower end initi guidanc
typic lower guidanc bp believ differ given acceler consumer healthcar
compani data factset pjc estim
page
front runner win north carolina ohio greenfield rfp
total revenu
new mexico plan award winner re-bid rfp incumb
medicaid member howev would surpris retain contract believ contract
challeng profit point view given comment peer recent announc
win new mexico re-bid estim contract could worth revenu ep
view front runner win ohio mltss delay late north carolina
rfp award date believ unh data analyt technolog capabl make attract
choic north carolina contract estim add revenu ep ohio believ
well posit win contract given solid star averag report card rate strong
market share hold adb dual contract view good proxi ltss
contract among public peer estim contract could revenu
medicaid contract win compani
vendor
vendor
vendor
enrol
compani data factset medicaid gov state procur pjc estim
page
total revenu
choos ff
share gain top brand
growth rate annual
vast major unh medicar supplement busi coverag introduct
unh reson well consum provid broad good choic senior
remain happi margin profil medicar supplement plan believ collis
medicar supplement plan marketplac help continu drive growth doubl digit
believ market underestim medicar advantag growth believ driven higher
share gain top brand
share gain top brand
pjchc survey kaiser pjc estim
expect growth rate long-term posit tailwind industri leader back
result consum survey peopl found major younger consum respond
age would will trade slightli smaller network less expens health insur
analysi use censu data age distribut combin survey estim impli penetr
realli per year vs consensu belief view posit estim current
hold market membership highest industri believ drive market share gain via
optum analyt platform grow consist provid system everi gain drive increment
ep penetr
page
continu activ deploy capit share repurchas
believ continu make invest optum specif optumcar also continu return capit sharehold
share repurchas guid dividend manag made clear intern capit deploy
mainli direct toward optum improv area technolog suit believ invest pay evidenc cost trend
come lower expect year believ place continu lower medic cost meanwhil confid
keep dividend pay-out ratio consist
like unh recent activ front purchas medic group empresa banmedica believ unh primari
 focu provid side increas vertic integr acquisit sca medexpress medic group see
vertic integr strategi way control cost top bottom offer multi-payor approach ensur deliveri high-qual
care believ due dilig decid purchas empresa banmedica compani analyz market year
decid make purchas see need improv qualiti effici cost healthcar chile columbia peru
region cover empresa banmedica believ capabl deliv believ continu capit attract
opportun avail
compani data factset pjc estim
page
compani data factset pjc estim
page
rais estim pt reflect tax reform
increas confid optum
ep vs consensu estim driven strong perform optum
estim consensu revenu estim consensu sg
bp y/i estim consensu optum revenu estim
consensu optum margin estim optumhealth revenu
estim optuminsight estim optumrx estim enrol
increas sequenti commerci estim medicaid in-lin estim
medicar in-lin estim dcp decreas day day cfo ni repurchas
outstand
increas estim price target reflect increas optim optum account impact
tax reform increas ep estim account drop
tax rate higher optuminsight revenu optuminsight increas revenu backlog
increas convers rate backlog lead increas optuminsight revenu account
increas estim increas pt base ep
lower multipl reflect multipl shift tax reform
compani data factset pjc estim
page
thousand except per share
invest incom
product sold
compani report piper jaffray co current disclosur inform compani found http //www piperjaffray com/researchdisclosur
